Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA clears IND for long-acting injectable antipsychotic based on MedinCell technology

Aug. 28, 2019

hIL-12 gene therapy can prolong survival in recurrent high-grade glioma patients

Aug. 28, 2019

Immunogenicity and efficacy animal studies of a new vaccine against Lassa virus confirm protection

Aug. 28, 2019

Reversible, selective, potent BTK inhibitors identified by Tethering-fragment-based screening

Aug. 28, 2019

Forward genetics identifies new immune player

Aug. 28, 2019

CPRIT grant supports Emtora's development of eRapa for familial adenomatous polyposis

Aug. 27, 2019

ADC Therapeutics and Freenome enter biomarker collaboration for ADCT-402 program

Aug. 27, 2019

Phase IIb CONDUCT study of cobitolimod in ulcerative colitis meets primary endpoint

Aug. 27, 2019

New global phase IIa study evaluates tezepelumab for moderate to very severe COPD

Aug. 27, 2019

Basilea completes enrollment in phase I study of oral BAL-101553 in brain cancer

Aug. 27, 2019

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...